Pesquisas alternativas:
nacl » natl (Expandir a Pesquisa), nac (Expandir a Pesquisa), nucl (Expandir a Pesquisa)
comor » comorb (Expandir a Pesquisa), comer (Expandir a Pesquisa), compr (Expandir a Pesquisa)
nacl » natl (Expandir a Pesquisa), nac (Expandir a Pesquisa), nucl (Expandir a Pesquisa)
comor » comorb (Expandir a Pesquisa), comer (Expandir a Pesquisa), compr (Expandir a Pesquisa)
1
“... the radiative properties and precipitation onset
in mixed-phase clouds by triggering ice formation...”
Obter o texto integral
Obter o texto integral
Artigo
2
Por Tinahones, F J, Gross, J L, Onaca, A, Cleall, S, Rodríguez, A
Publicado no Diabetes Obes Metab (2014)
“... daily (IGL; n = 240) over 24 weeks in patients with HbA1c 7.5–10.5% and fasting plasma glucose ≤6.7 mmol...”Publicado no Diabetes Obes Metab (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Sun, Alexander, Bae, Kyounghwa, Gore, Elizabeth M., Movsas, Benjamin, Wong, Stuart J., Meyers, Christina A., Bonner, James A., Schild, Steven E., Gaspar, Laurie E., Bogart, Jeffery A., Werner-Wasik, Maria, Choy, Hak
Publicado em 2011
“... no overall survival (OS) benefit for PCI in stage III non–small-cell lung cancer (NSCLC) at 1 year. However...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Dupoiron, D., Stachowiak, A., Loewenstein, O., Ellery, A., Kremers, W., Bosse, B., Hopp, M.
Publicado no Eur J Pain (2017)
“...‐week open‐label extension phase of the 5‐week randomized comparative study in patients with non...”Publicado no Eur J Pain (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Dupoiron, D., Stachowiak, A., Loewenstein, O., Ellery, A., Kremers, W., Bosse, B., Hopp, M.
Publicado no Eur J Pain (2017)
“.../80 mg PR compared with oxycodone prolonged‐release formulation (OxyPR) in a randomised controlled...”Publicado no Eur J Pain (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Bekker, Linda-Gail, Roux, Surita, Sebastien, Elaine, Yola, Ntando, Amico, K Rivet, Hughes, James P, Marzinke, Mark A, Hendrix, Craig W, Anderson, Peter L, Elharrar, Vanessa, Stirratt, Michael, Rooney, James F, Piwowar-Manning, Estelle, Eshleman, Susan H, McKinstry, Laura, Li, Maoji, Dye, Bonnie J, Grant, Robert M
Publicado no Lancet HIV (2017)
“... of non-daily PrEP regimens in adult women. METHODS: We did a randomised, open-label, phase 2 clinical...”Publicado no Lancet HIV (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Rodbard, H. W., Cariou, B., Pieber, T. R., Endahl, L. A., Zacho, J., Cooper, J. G.
Publicado no Diabetes Obes Metab (2016)
“... in separate injections). METHODS: This 26‐week, open‐label, treat‐to‐target, phase IIIb, non‐inferiority trial...”Publicado no Diabetes Obes Metab (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
“... was high compared with that of controls or patients with cystic fibrosis. The extractable water phase...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Novello, S, Mazières, J, Oh, I -J, de Castro, J, Migliorino, M R, Helland, Å, Dziadziuszko, R, Griesinger, F, Kotb, A, Zeaiter, A, Cardona, A, Balas, B, Johannsdottir, H K, Das-Gupta, A, Wolf, J
Publicado no Ann Oncol (2018)
“...: ALUR (MO29750; NCT02604342) was a randomized, multicenter, open-label, phase III trial of alectinib...”Publicado no Ann Oncol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Cohen, Craig R., Brown, Joelle, Moscicki, Anna-Barbara, Bukusi, Elizabeth A., Paull, Jeremy R. A., Price, Clare F., Shiboski, Stephen
Publicado em 2011
“... 3 or 4 AEs, or serious AEs occurred. Twenty-five (71%) participants in the VivaGel arm compared...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Lin, Jianqing, Zahurak, Marianna, Beer, Tomasz M., Ryan, Charles. J., Wilding, George, Mathew, Paul, Morris, Michael, Callahan, Jennifer. A., Gordon, Gilad, Reich, Steven D., Carducci, Michael A., Antonarakis, Emmanuel S.
Publicado em 2011
“... was defined as a ≥50% increase (and >5 ng/mL) in PSA from baseline or post-treatment nadir. Endpoints included...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
13
“... made the situation critical. Aims: Our aim was to compare the efficacy of the daily...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Hirsch, Fred R., Kabbinavar, Fairooz, Eisen, Tim, Martins, Renato, Schnell, Fredrick M., Dziadziuszko, Rafal, Richardson, Katherine, Richardson, Frank, Wacker, Bret, Sternberg, David W., Rusk, Jason, Franklin, Wilbur A., Varella-Garcia, Marileila, Bunn, Paul A., Camidge, D. Ross
Publicado em 2011
“...). We report the results of a randomized, phase II study of erlotinib alone or intercalated...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Keller, Marla J., Carpenter, Colleen A., Lo, Yungtai, Einstein, Mark H., Liu, Congzhou, Fredricks, David N., Herold, Betsy C.
Publicado em 2012
“... be an effective topical non-hormonal contraceptive. This study was designed to evaluate the safety of vaginal...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Ihlen, Espen A. F., van Schooten, Kimberley S., Bruijn, Sjoerd M., van Dieën, Jaap H., Vereijken, Beatrix, Helbostad, Jorunn L., Pijnappels, Mirjam
Publicado no Front Aging Neurosci (2018)
“... fallers in a 6 months follow-up period, and an equal number of non-falling controls matched by age, weight...”Publicado no Front Aging Neurosci (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Halmos, Balazs, Pennell, Nathan A., Fu, Pingfu, Saad, Shumaila, Gadgeel, Shirish, Otterson, Gregory A., Mekhail, Tarek, Snell, Michael, Kuebler, J. Philip, Sharma, Neelesh, Dowlati, Afshin
Publicado no Oncologist (2015)
“... progression remains unclear. MATERIALS AND METHODS. This was a randomized phase II study of chemotherapy (arm...”Publicado no Oncologist (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Chung, Steve S, Fakhoury, Toufic A, Hogan, R Edward, Nagaraddi, Venkatesh N, Blatt, Ilan, Lawson, Balduin, Arnold, Stephan, Anders, Bob, Clark, Annie M, Laine, Dawn, Meadows, R Shawn, Halvorsen, Mark B
Publicado em 2014
“... to three concomitant antiepileptic drugs. METHODS: In this global phase III study (PREVAIL; NCT01142193...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Blumenschein, G. R., Smit, E. F., Planchard, D., Kim, D.-W., Cadranel, J., De Pas, T., Dunphy, F., Udud, K., Ahn, M.-J., Hanna, N. H., Kim, J.-H., Mazieres, J., Kim, S.-W., Baas, P., Rappold, E., Redhu, S., Puski, A., Wu, F. S., Jänne, P. A.
Publicado no Ann Oncol (2015)
“... of MEK1/MEK2, demonstrated preclinical and clinical activity in KRAS-mutant NSCLC. We report a phase II...”Publicado no Ann Oncol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Aronson, R., Reznik, Y., Conget, I., Castañeda, J. A., Runzis, S., Lee, S. W., Cohen, O.
Publicado no Diabetes Obes Metab (2016)
“...AIMS: To compare insulin pump therapy and multiple daily injections (MDI) in patients with type 2...”Publicado no Diabetes Obes Metab (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo